Fatal liver failure after high-dose glucocorticoid pulse therapy in a patient with severe thyroid eye disease

scientific article published on 01 June 2000

Fatal liver failure after high-dose glucocorticoid pulse therapy in a patient with severe thyroid eye disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1089/THY.2000.10.521
P698PubMed publication ID10907999

P2093author name stringWeissel M
Hauff W
P433issue6
P921main subjectliver failureQ970208
eye diseaseQ3041498
P304page(s)521
P577publication date2000-06-01
P1433published inThyroidQ15709940
P1476titleFatal liver failure after high-dose glucocorticoid pulse therapy in a patient with severe thyroid eye disease
P478volume10

Reverse relations

cites work (P2860)
Q38784922Acute liver damage following intravenous glucocorticoid treatment for Graves' ophthalmopathy.
Q26827429Acute thyroid eye disease (TED): principles of medical and surgical management
Q38877933Advances in treatment of active, moderate-to-severe Graves' ophthalmopathy
Q36216631An update on medical management of Graves' ophthalmopathy
Q46542938Autoimmune hepatitis during intravenous glucocorticoid pulse therapy for Graves' ophthalmopathy treated successfully with glucocorticoids themselves.
Q34774478Graves' ophthalmopathy: a rational approach to treatment
Q58695115Influence of Methylprednisolone Pulse Therapy on Liver Function in Patients with Graves' Orbitopathy
Q92341018Life-threatening complications of high doses of intravenous methylprednisolone for treatment of Graves' orbitopathy
Q35843262Liver Dysfunction Associated with Intravenous Methylprednisolone Pulse Therapy in Patients with Graves' Orbitopathy
Q91973934Liver injury after methylprednisolone pulses: A disputable cause of hepatotoxicity. A case series and literature review
Q55283252Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients.
Q35582456Liver injury induced by high-dose methylprednisolone therapy: a case report and brief review of the literature
Q36799086Management of Graves' ophthalmopathy
Q42283354Methimazole-induced liver injury overshadowed by methylprednisolone pulse therapy: Case report.
Q35785158Novel aspects of immunosuppressive and radiotherapy management of Graves' ophthalmopathy
Q30883875Prospectively recorded and MedDRA-coded safety data of intravenous methylprednisolone therapy in Graves' orbitopathy
Q41844069Pulse dexamethasone therapy versus pulse methylprednisolone therapy for treatment of Graves's ophthalmopathy
Q36349128Safety Profile and Effects of Pulsed Methylprednisolone on Vital Signs in Thyroid Eye Disease
Q39552770Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' orbitopathy.
Q34014090The eye and thyroid disease
Q90496708Therapeutic Effect of Guggulsterone in Primary Cultured Orbital Fibroblasts Obtained From Patients with Graves' Orbitopathy
Q44286473Treatment of Graves' ophthalmopathy with high-dose intravenous methylprednisolone: a comparison of two dosing regimens
Q50072191[Driving competency after combined treatment with methylprednisolone and orbital radiotherapy for endocrine orbitopathy].

Search more.